- 2.9Impact Factor
- 5.2CiteScore
- 19 daysTime to First Decision
Clinical Studies on Bioavailability, Biotransformation, Biokinetics and Bioeffects of Phytochemicals
This special issue belongs to the section “Pharmacology“.
Special Issue Information
Dear Colleagues,
The health-promoting effects of phytochemicals strictly depend on their oral bioavailability, which, in turn, relies on i) the individual biotransformation systems; ii) the chemical structure and properties of each compound; and iii) the complexity of the plant matrix consisting of seeds, leaves, roots, stems, flowers, and other plant tissues and organs. After intake, bioactive compounds have to be absorbed, distributed, and metabolized before reaching the target tissues and cells; finally, the metabolites of native compounds are excreted in urine and feces, mainly as water-soluble conjugates (methyl, glucuronide, and sulfate derivatives). The gastrointestinal tract, the systemic circulation, and the urinary system are involved in these complex and coordinated biotransformation processes including enterohepatic circulation, and Phase I (oxidation, reduction and hydrolysis) and Phase II (conjugation) metabolisms in enterocytes and hepatocytes. Finally, phytochemicals not absorbed in the small intestine reach the large intestine where they are biotransformed by the colonic microbiota. Indeed, though phytochemicals are commonly considered “natural” products, i.e., safe and healthy, it is not actually always so: Plant metabolites are recognized as xenobiotics by the human organism, and therefore, they are extensively metabolized.
In this very wide context, we invite investigators to submit both original research and review articles that explore all these aspects.
Prof. Dr. Marcello Iriti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nutraceuticals
- functional foods
- phytotherapeutics
- gut microbiota
- metabolomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

